World’s First Infant Treated with Customized CRISPR

STAT News reported May 26 that 6-month-old “Baby KJ” received a bespoke CRISPR–Cas9 infusion targeting a rare metabolic disorder. It’s the first N=1 CRISPR therapy under FDA supervision, demonstrating